The Australia oxygen concentrators market was valued at USD 29.01 Million in 2025 and is expected to grow at a CAGR of 5.50%, reaching USD 49.55 Million by 2035. The market growth is driven by the rising prevalence of respiratory diseases and an increasing preference for home healthcare solutions. The growing demand for portable and user-friendly devices, combined with technological advancements in oxygen delivery systems, is expected to enhance patient accessibility and convenience, thereby supporting market growth throughout the forecast period.
Base Year
Historical Period
Forecast Period
According to Asthma Australia, asthma ranked as the 8th highest disease burden in 2023-2024 with an age-standardized rate of 5.3 per 1,000 population, driving higher oxygen concentrator demand and contributing to market growth.
Rising prevalence of respiratory diseases, increasing preference for home healthcare, and technological advancements in portable oxygen concentrators are among the key factors driving consistent growth in the market.
Key players are expanding market growth through strategic collaborations, continuous product innovations, and broader distribution networks, enabling improved accessibility and accelerating adoption of advanced oxygen concentrator solutions across diverse healthcare settings.
Compound Annual Growth Rate
5.5%
Value in USD Million
2026-2035
*this image is indicative*
Oxygen concentrators are medical devices designed to provide supplemental oxygen to patients with respiratory conditions, enhancing oxygen levels in the blood and supporting better breathing. They are widely used in both clinical settings and home healthcare, offering portability, ease of use, and continuous oxygen delivery. The market was valued at USD 29.01 Million in 2025. The market is expanding due to the increasing prevalence of chronic respiratory diseases and the growing adoption of home healthcare services. The rising demand for portable and technologically advanced devices is expected to drive market growth further during the forecast period, thereby supporting patient accessibility and convenience.
Rising prevalence of COPD to Accelerate Market Growth
The rising prevalence of chronic obstructive pulmonary disease (COPD) remains a significant growth driver for the market. According to the Australian Institute of Health and Welfare, around 638,000 people were estimated to be living with COPD in 2022. In March 2023, it was further reported that COPD accounted for 3.6% of the total disease burden and half of the burden from respiratory conditions. With hospitalizations and healthcare spending increasing, the demand for advanced oxygen concentrators is set to strengthen market value during the forecast period.
Some of the trends in the market include growing government support for oxygen therapy and increasing efforts to expand access to oxygen therapy.
Government Support for Oxygen Therapy is Likely to Boost Market Value
One key trend shaping the market is the growing government support for oxygen therapy in aged care. In June 2025, an update highlighted the continuation of the oxygen supplement provided to residential and home care service providers, ensuring patients with long-term medical needs receive consistent oxygen support. Such initiatives enhance access to essential respiratory care while reducing the financial burden on providers. This trend is expected to significantly strengthen market growth by driving wider adoption of oxygen concentrators across aged care settings.
Expanding Access to Oxygen Therapy to Enhance Australia Oxygen Concentrators Market Value
The increasing emphasis on expanding access to oxygen therapy as part of essential healthcare is a significant trend shaping the market. In April 2022, the Murdoch Children’s Research Institute, in collaboration with the Clinton Health Access Initiative, advanced programs focused on scaling oxygen systems and integrating pulse oximetry to address hypoxaemia. These initiatives highlight the role of innovation and global collaboration in improving respiratory care, a development expected to significantly boost market growth throughout the forecast period.
Portable Oxygen Concentrators to Witness Significant Growth for Segmentation by Product Type
The market is segmented by product type into portable oxygen concentrators and stationary oxygen concentrators. Both segments are essential in meeting patient requirements across different care settings. The fixed oxygen concentrators segment, accounted for 50% share in the historical period. Their reliability, efficiency, and suitability for continuous oxygen delivery contribute to their stronger adoption, positioning them ahead of portable variants in overall market growth.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Royal Philips supplies both home and portable oxygen concentrators in Australia through its Respironics line, including the energy-efficient EverFlo (lightweight, low maintenance, quiet) and the rugged SimplyGo portable concentrators designed for continuous-flow mobility. These devices are listed in the Therapeutic Goods Administration (TGA) registry, indicating regulatory approval and widespread availability in the Australian healthcare market.
Invacare offers a range of oxygen concentrators in Australia, including the stationary Perfecto2 V (noted for quiet, maintenance-free operation for up to 3 years) and Portable models like SOLO2, leveraging Sensi-Pulse technology for adaptive oxygen dosing. Historical Phillipson-level safety recalls (e.g., Perfecto2 and Platinum models due to fire risk) are documented through the TGA, underscoring Invacare’s compliance with stringent regulation and post-market vigilance.
Inogen is recognized in Australia for its innovative portable oxygen concentrators—especially the lightweight Inogen One G4 (approx. 1.3 kg) and the powerful G5 model with extended battery life (6–13 hours) and multiple flow settings (1–6). These devices are commonly sold via Australian medical suppliers and supported by local service networks.
Drive DeVilbiss has a strong presence in the Australian oxygen concentrator market with its stationary models Compact 525 (5 L/min) and 1025 (10 L/min). These units are valued for compact design, high oxygen purity, quiet operation, and safety features like OSD® monitoring sensors. They are widely available at Australian healthcare equipment suppliers and authorized distributors.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Nidek Medical, GCE Group, and Air Liquide Healthcare.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Market Breakup by Technology
Market Breakup by Application
Market Breakup by End User
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share